1. Home
  2. PRTC vs ORN Comparison

PRTC vs ORN Comparison

Compare PRTC & ORN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTC
  • ORN
  • Stock Information
  • Founded
  • PRTC 2015
  • ORN 1994
  • Country
  • PRTC United States
  • ORN United States
  • Employees
  • PRTC N/A
  • ORN N/A
  • Industry
  • PRTC Biotechnology: Pharmaceutical Preparations
  • ORN Military/Government/Technical
  • Sector
  • PRTC Health Care
  • ORN Industrials
  • Exchange
  • PRTC Nasdaq
  • ORN Nasdaq
  • Market Cap
  • PRTC 413.5M
  • ORN 339.4M
  • IPO Year
  • PRTC N/A
  • ORN 2007
  • Fundamental
  • Price
  • PRTC $16.75
  • ORN $7.18
  • Analyst Decision
  • PRTC Buy
  • ORN Strong Buy
  • Analyst Count
  • PRTC 1
  • ORN 2
  • Target Price
  • PRTC $45.00
  • ORN $11.25
  • AVG Volume (30 Days)
  • PRTC 5.6K
  • ORN 348.8K
  • Earning Date
  • PRTC 08-28-2025
  • ORN 10-29-2025
  • Dividend Yield
  • PRTC N/A
  • ORN N/A
  • EPS Growth
  • PRTC N/A
  • ORN N/A
  • EPS
  • PRTC 0.20
  • ORN 0.27
  • Revenue
  • PRTC $6,391,000.00
  • ORN $837,494,000.00
  • Revenue This Year
  • PRTC N/A
  • ORN $4.83
  • Revenue Next Year
  • PRTC N/A
  • ORN $8.34
  • P/E Ratio
  • PRTC $7.61
  • ORN $26.36
  • Revenue Growth
  • PRTC 1265.60
  • ORN 15.85
  • 52 Week Low
  • PRTC $13.30
  • ORN $4.64
  • 52 Week High
  • PRTC $24.99
  • ORN $9.95
  • Technical
  • Relative Strength Index (RSI)
  • PRTC 43.45
  • ORN 46.23
  • Support Level
  • PRTC $15.78
  • ORN $7.08
  • Resistance Level
  • PRTC $16.50
  • ORN $7.66
  • Average True Range (ATR)
  • PRTC 0.57
  • ORN 0.33
  • MACD
  • PRTC -0.18
  • ORN 0.09
  • Stochastic Oscillator
  • PRTC 25.17
  • ORN 60.16

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

About ORN Orion Group Holdings Inc. Common

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar and mesh across the light commercial, structural and other associated business areas.

Share on Social Networks: